Talk to our Consultant - Human Milk Oligosaccharides Market Size, Demand

Global Human Milk Oligosaccharides (HMO) Market Research Report: Forecast (2023-2028)

By Type (2’FL, 3’FL, 3’SL, 6’SL), By Application (Infant formula, Functional food & beverage, Food supplements, Others), By Concentration (Neutral, Acidic, Others), By Distribution Channel (Hypermarke... ... ribution Channel (Hypermarkets & Supermarkets, Drug store or pharmacy, Mass merchandiser, Departmental Stores, Mono-brand Store, Specialty stores), By Region (North America, South America, Europe, Asia-Pacific, The Middle East and Africa), By Company (Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd, DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others) Read more

Food & Beverages
May 2023
Pages 179
Report Format: PDF, Excel, PPT

Market Definition

Human Milk Oligosaccharides (HMOs) are a complex group of carbohydrates naturally present in human breast milk. After lactose and lipids, they are the third most abundant solid component in breast milk and are composed of various monosaccharides (simple sugars) linked together in different arrangements.

Market Insights & Analysis: Global Human Milk Oligosaccharides (HMO) Market (2023-28)

The Global Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28. The growth of the market would be propelled mainly by increasing concerns among consumers regarding health & wellness, growing awareness about the importance of optimal nutrition for infants as well as the benefits of HMOs. Besides, the ever-increased focus on infant health & development, coupled with technological advancements in HMO production methods, are other prominent aspects expected to drive the market in the future.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	21.75%
Regions Covered	North America: The US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: The UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa
Key Companies Profiled	Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others
Unit Denominations	USD Million/Billion

Several companies operating in the industry are massively investing in R&D activities to develop new HMO types, improve production processes, and expand the range of applications in order to boost innovations & product development. The rising infant population, urbanization, increasing disposable incomes, and changing lifestyles continue to augment the demand for HMOs, and they are being increasingly incorporated into infant formula products to enhance their nutritional value and mimic the benefits of breast milk.

Moreover, favorable government policies toward encouraging the use of HMOs, the mounting demand for dietary supplements that help improve metabolic activity by promoting bacterial growth, and the increasing application of HMOs in pharmaceuticals, infant formulas, & medicinal foods are also anticipated to spur growth in the Global Human Milk Oligosaccharides (HMO) Market through 2028.

Global Human Milk Oligosaccharides (HMO) Market Research Report (2023-2028) - Table of Contents

Market Segmentation
Introduction
1. Type Definition
2. Research Process
3. Assumptions
Executive Summary
Global Human Milk Oligosaccharides (HMO) Market Regulations and Policy
Global Human Milk Oligosaccharides (HMO) Market Trends & Developments
Global Human Milk Oligosaccharides (HMO) Market Supply Chain Analysis
Global Human Milk Oligosaccharides (HMO) Market Dynamics
1. Drivers
2. Challenges
Global Human Milk Oligosaccharides (HMO) Market Hotspot & Opportunities
Global Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type
    1. 2’FL- Market Size & Forecast 2018-2028, (USD Million)
    2. 3’FL- Market Size & Forecast 2018-2028, (USD Million)
    3. 3’SL- Market Size & Forecast 2018-2028, (USD Million)
    4. 6’SL- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application
    1. Infant formula- Market Size & Forecast 2018-2028, (USD Million)
    2. Functional food & beverage- Market Size & Forecast 2018-2028, (USD Million)
    3. Food supplements- Market Size & Forecast 2018-2028, (USD Million)
    4. Others-Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration
    1. Neutral- Market Size & Forecast 2018-2028, (USD Million)
    2. Acidic- Market Size & Forecast 2018-2028, (USD Million)
    3. Others-- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel
    1. Hypermarkets & Supermarkets- Market Size & Forecast 2018-2028, (USD Million)
    2. Drug store or pharmacy- Market Size & Forecast 2018-2028, (USD Million)
    3. Mass merchandiser- Market Size & Forecast 2018-2028, (USD Million)
    4. Departmental Stores- Market Size & Forecast 2018-2028, (USD Million)
    5. Mono-brand Store-Market Size & Forecast 2018-2028, (USD Million)
    6. Specialty stores-Market Size & Forecast 2018-2028, (USD Million)
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Asia-Pacific
    5. The Middle East and Africa
  6. By Company
    1. Market Share
    2. Competition Characteristics
North America Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2018-2028, (USD Million)
    2. By Application- Market Size & Forecast 2018-2028, (USD Million)
    3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
    4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
4. Canada Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2018-2028, (USD Million)
    2. By Application- Market Size & Forecast 2018-2028, (USD Million)
5. Mexico Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2018-2028, (USD Million)
    2. By Application- Market Size & Forecast 2018-2028, (USD Million)
    3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
    4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
South America Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2018-2028, (USD Million)
    2. By Application- Market Size & Forecast 2018-2028, (USD Million)
    3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
    4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
4. Argentina Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Type- Market Size & Forecast 2018-2028, (USD Million)
    2. By Application- Market Size & Forecast 2018-2028, (USD Million)
    3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
    4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Europe Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
3. By Country
  1. Germany
  2. The UK
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Germany Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
The UK Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
France Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Italy Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Spain Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Asia-Pacific Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
3. By Country
  1. China
  2. Japan
  3. Australia
  4. India
  5. South Korea
  6. Rest of Asia Pacific
China Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Japan Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Australia Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
India Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
South Korea Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Middle East and Africa Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
3. By Country
  1. South Africa
  2. The UAE
  3. Saudi Arabia
  4. Rest of Middle East and Africa
South Africa Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
The UAE Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Saudi Arabia Human Milk Oligosaccharides (HMO) Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Type- Market Size & Forecast 2018-2028, (USD Million)
  2. By Application- Market Size & Forecast 2018-2028, (USD Million)
  3. By Concentration- Market Size & Forecast 2018-2028, (USD Million)
  4. By Distribution Channel- Market Size & Forecast 2018-2028, (USD Million)
Competitive Outlook
1. Company Profiles
  1. Biosynth Carbosynth
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Chr. Hansen Holding A/S
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Dextra Laboratories Ltd
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. DuPont Nutrition & Biosciences
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Elicityl S.A.
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Glycosyn
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Inbiose NV
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Medolac Laboratories
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Nestle Health Science
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. ROYAL DSM
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. BASF SE
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Abbott Laboratories
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. GNUBIOTICS Sciences S.A.
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Dextra Laboratories
    1. Business Description
    2. Type Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Others
    1. Conagen Inc.
    2. Medolac Laboratories
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying